Association Study of -2548A/G Polymorphism of Leptin Gene with Antipsychotics-Induced Weight Gain / 대한정신약물학회지
Korean Journal of Psychopharmacology
; : 423-428, 2006.
Article
de Ko
| WPRIM
| ID: wpr-163637
Bibliothèque responsable:
WPRO
ABSTRACT
OBJECTIVES: Leptin, the product of ob gene, is secreted by adipocytes and signals the size of peripheral fat stores to the brain. Several evidences indicate that a polymorphism in the promoter region (-2548A/G) of leptin gene is associated with antipsychotics-induced weight gain. This study aims at investigating the association between the -2548A/G polymorphism of leptin gene and antipsychotics-induced weight gain in Korean schizophrenia patients. METHODS: Seventy one patients with schizophrenia were recruited. All of the subjects were antipsychotics-naive or free of antipsychotic drugs for the previous 3 months. Genotyping was done for the -2548A/G polymorphism of leptin gene. Body mass index (BMI) was measured at baseline, after 4 weeks and after 8 weeks of antipsychotic drug treatment. The subjects were grouped on the basis of the presence or absence of the G allele (AA vs. AG/GG) and two-sided t tests for independent samples was used to analyze the relationship between two genotype groups and BMI change. And a chi-square analysis was conducted to test the association between the allele type and BMI change. RESULTS: We could not find any association between the -2548A/G polymorphism of leptin gene and antipsychotics-induced weight gain. CONCLUSION: Our data do not support the involvement of the -2548A/G polymorphism of leptin gene in antipsychotics-induced weight gain in the acute treatment phase.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Schizophrénie
/
Neuroleptiques
/
Encéphale
/
Prise de poids
/
Indice de masse corporelle
/
Régions promotrices (génétique)
/
Adipocytes
/
Leptine
/
Allèles
/
Génotype
Limites du sujet:
Humans
langue:
Ko
Texte intégral:
Korean Journal of Psychopharmacology
Année:
2006
Type:
Article